 Risk Assessment
"Risk Assessment" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)
| Descriptor ID |
D018570
|
| MeSH Number(s) |
E05.318.740.600.800.715 N04.452.871.715 N05.715.360.750.625.700.690 N06.850.505.715 N06.850.520.830.600.800.715
|
| Concept/Terms |
Risk Assessment- Risk Assessment
- Assessments, Risk
- Risk Assessments
- Assessment, Risk
Benefit-Risk Assessment- Benefit-Risk Assessment
- Assessment, Benefit-Risk
- Assessments, Benefit-Risk
- Benefit Risk Assessment
- Benefit-Risk Assessments
- Risk-Benefit Assessment
- Assessment, Risk-Benefit
- Assessments, Risk-Benefit
- Risk Benefit Assessment
- Risk-Benefit Assessments
|
Below are MeSH descriptors whose meaning is more general than "Risk Assessment".
Below are MeSH descriptors whose meaning is more specific than "Risk Assessment".
This graph shows the total number of publications written about "Risk Assessment" by people in this website by year, and whether "Risk Assessment" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 | | 2002 | 0 | 2 | 2 | | 2004 | 0 | 2 | 2 | | 2005 | 0 | 1 | 1 | | 2006 | 0 | 4 | 4 | | 2007 | 0 | 3 | 3 | | 2008 | 0 | 6 | 6 | | 2009 | 0 | 3 | 3 | | 2010 | 0 | 3 | 3 | | 2011 | 0 | 12 | 12 | | 2012 | 0 | 7 | 7 | | 2013 | 0 | 2 | 2 | | 2014 | 0 | 2 | 2 | | 2015 | 0 | 8 | 8 | | 2016 | 0 | 8 | 8 | | 2017 | 1 | 7 | 8 | | 2018 | 2 | 9 | 11 | | 2019 | 1 | 10 | 11 | | 2020 | 1 | 6 | 7 | | 2021 | 1 | 6 | 7 | | 2022 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Risk Assessment" by people in Profiles.
-
Snyder CL. Weighing the Risks and Benefits of Nonoperative Management of Appendicitis. Pediatrics. 2022 05 01; 149(5).
-
Lantos JD, Yeh HW, Raza F, Connelly M, Goggin K, Sullivant SA. Suicide Risk in Adolescents During the COVID-19 Pandemic. Pediatrics. 2022 02 01; 149(2).
-
Nordström T, Discacciati A, Bergman M, Clements M, Aly M, Annerstedt M, Glaessgen A, Carlsson S, Jäderling F, Eklund M, Grönberg H. Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial. Lancet Oncol. 2021 09; 22(9):1240-1249.
-
Aly DM, Erickson LA, Hancock H, Apperson JW, Gaddis M, Shirali G, Goudar S. Ability of Video Telemetry to Predict Unplanned Hospital Admissions for Single Ventricle Infants. J Am Heart Assoc. 2021 08 17; 10(16):e020851.
-
Lou LJ, Carr MF, Lantos JD, Fanaroff JM, Mercurio MR. Balancing risks and benefits of open notes for neonatology. J Perinatol. 2021 09; 41(9):2370-2371.
-
Patton SR, Feldman K, Majidi S, Noser A, Clements MA. Identifying HbA1c trajectories and modifiable risk factors of trajectories in 5- to 9-year-olds with recent-onset type 1 diabetes from the United States. Diabet Med. 2021 09; 38(9):e14637.
-
van Wessel DBE, Thompson RJ, Gonzales E, Jankowska I, Shneider BL, Sokal E, Grammatikopoulos T, Kadaristiana A, Jacquemin E, Spraul A, Lipinski P, Czubkowski P, Rock N, Shagrani M, Broering D, Algoufi T, Mazhar N, Nicastro E, Kelly D, Nebbia G, Arnell H, Fischler B, Hulscher JBF, Serranti D, Arikan C, Debray D, Lacaille F, Goncalves C, Hierro L, Muñoz Bartolo G, Mozer-Glassberg Y, Azaz A, Brecelj J, Dezsofi A, Luigi Calvo P, Krebs-Schmitt D, Hartleif S, van der Woerd WL, Wang JS, Li LT, Durmaz Ö, Kerkar N, Hørby Jørgensen M, Fischer R, Jimenez-Rivera C, Alam S, Cananzi M, Laverdure N, Targa Ferreira C, Ordonez F, Wang H, Sency V, Mo Kim K, Chen HL, Carvalho E, Fabre A, Quintero Bernabeu J, Alonso EM, Sokol RJ, Suchy FJ, Loomes KM, McKiernan PJ, Rosenthal P, Turmelle Y, Rao GS, Horslen S, Kamath BM, Rogalidou M, Karnsakul WW, Hansen B, Verkade HJ. Impact of Genotype, Serum Bile Acids, and Surgical Biliary Diversion on Native Liver Survival in FIC1 Deficiency. Hepatology. 2021 08; 74(2):892-906.
-
Pollard JA, Guest E, Alonzo TA, Gerbing RB, Loken MR, Brodersen LE, Kolb EA, Aplenc R, Meshinchi S, Raimondi SC, Hirsch B, Gamis AS. Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531. J Clin Oncol. 2021 10 01; 39(28):3149-3160.
-
Dahlén T, Clements M, Zhao J, Olsson ML, Edgren G. An agnostic study of associations between ABO and RhD blood group and phenome-wide disease risk. Elife. 2021 04 27; 10.
-
Kim MH, Nguyen A, Lo M, Kumar SR, Bucuvalas J, Glynn EF, Hoffman MA, Fischer R, Emamaullee J. Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver Disease. Transplantation. 2021 01 01; 105(1):18-22.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|